Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

View Larger Image

Past Issues Free Subscriptions

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• mAb Production
• Protein Characterization
• Protein Detection
• Protein Production
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• Page 2 of 2 (27 items) First 1 2 

• GEN Podcasts

• CLINICAL TRIAL ETHICS IN THE DEVELOPING WORLD
  - Jonathan Kimmelman, Ph.D., Assistant Professor in the Biomedical Ethics Unit/Social Studies of Medicine Department, McGill University
• NEW MODEL FOR CREATING A DRUG DISCOVERY COMPANY
  - Interview with Ben Conway, Founder and Managing Director, Boston-based Johnston Blakely and Co., and Isaac Ro, Senior Analyst, Boston-based Leerink Swann
• IMPLICATIONS OF GINA FOR THE BIOTECH AND PHARMA INDUSTRIES
  - Interview with Sharon Terry, President and CEO of the Genetic Alliance
• INTERACTING WITH THE FDA-ISSUES AND STRATEGIES
  - Interview with Bruce Mackler, Ph.D., J.D., senior advisor on FDA matters and due diligence concerns to financial groups and investment companies
• TRENDS IN THE GLOBALIZATION OF BIOTECHNOLOGY
  - Exclusive GEN Panel Discussion with Four Co-Chairs of the Upcoming Biotechnology Industry Organization's (BIO) Annual International Convention
• VENTURE CAPITAL TRENDS FOR 2008
  - Interview with Brian Hughes and Packy Kelly, co-leaders of KPMG’s venture capital practice.
• BIOGEN IDEC'S NOVEL INNOVATION INCUBATOR FACILITY
  - Interview with Rainer Fuchs, Ph.D., Vice President and Executive Director of the Biogen Idec Innovation Incubator (bi3)

• Page 2 of 2 (27 items) First 1 2